BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 21, 2020
View Archived Issues
Another obstacle to universal flu vaccine
Read More
ORIC Pharmaceuticals' OP-4954 displays selective glucocorticoid receptor antagonism
Read More
Promising preclinical data for novel lymph node targeting COVID-19 vaccine
Read More
Phosphodiesterase PDE3A and PDE3B inhibitors described by Bayer, The Broad Institute
Read More
Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent ADORA2A/B antagonists
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical discovers HBV capsid assembly inhibitors
Read More
New opioid receptor ligands identified at Yangtze River Pharmaceutical
Read More
Esteve presents dual sigma1 and mu-opioid receptor ligands
Read More
Genmab initiates first-in-human study of GEN-1044
Read More
Takeda starts enrollment in first-in-human trial of TAK-102
Read More
Enrollment ongoing in phase I/II study of TAEK-VAC-HerBy vaccine
Read More
First participant vaccinated in phase III study of MenABCWY meningitis vaccine candidate
Read More
Tankyrase inhibition with OM-153 shows potential for immuno-oncology
Read More
Ascletis completed bridging study of ASC-18 FDC pill for the treatment of hepatitis C
Read More
Repurposing of low-cost generic nafamostat as COVID-19 therapy
Read More
First healthy volunteer dosed in phase I clinical program of IMU-856
Read More
Positive early data for lead mRNA COVID-19 vaccine candidate BNT-162b2
Read More
Orally active STING agonists stimulate innate immunity
Read More
FDA approves Kesimpta for the treatment of relapsing multiple sclerosis
Read More
Imfinzi receives Japanese approval for the treatment of extensive-stage SCLC
Read More
First-in-human proof-of-concept trial for HBV treatment ALG-010133 begins
Read More